AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: ESPINELINGROFF A BARCHIESI F HAZEN KC MARTINEZSUAREZ JV SCALISE G
Citation: A. Espinelingroff et al., STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING AND CLINICAL RELEVANCE, MEDICAL MYCOLOGY, 36, 1998, pp. 68-78

Authors: PFALLER MA MESSER SA HOLLIS RJ ESPINELINGROFF A GHANNOUM MA PLAVAN H KILLIAN SB KNAPP CC
Citation: Ma. Pfaller et al., MULTISITE REPRODUCIBILITY OF MIC RESULTS BY THE SENSITITRE(R) YEASTONE COLORIMETRIC ANTIFUNGAL SUSCEPTIBILITY PANEL, Diagnostic microbiology and infectious disease, 31(4), 1998, pp. 543-547

Authors: ESPINELINGROFF A STOCKMAN L ROBERTS G PINCUS D POLLACK J MARLER J
Citation: A. Espinelingroff et al., COMPARISON OF RAPID YEAST PLUS SYSTEM WITH API 20C SYSTEM FOR IDENTIFICATION OF COMMON, NEW, AND EMERGING YEAST PATHOGENS, Journal of clinical microbiology, 36(4), 1998, pp. 883-886

Authors: ESPINELINGROFF A
Citation: A. Espinelingroff, COMPARISON OF IN-VITRO ACTIVITIES OF THE NEW TRIAZOLE SCH56592 AND THE ECHINOCANDINS MK-0991 (L-743,872) AND LY303366 AGAINST OPPORTUNISTICFILAMENTOUS AND DIMORPHIC FUNGI AND YEASTS, Journal of clinical microbiology, 36(10), 1998, pp. 2950-2956

Authors: ESPINELINGROFF A
Citation: A. Espinelingroff, IN-VITRO ACTIVITY OF THE NEW TRIAZOLE VORICONAZOLE (UK-109,496) AGAINST OPPORTUNISTIC FILAMENTOUS AND DIMORPHIC FUNGI AND COMMON AND EMERGING YEAST PATHOGENS, Journal of clinical microbiology, 36(1), 1998, pp. 198-202

Authors: ODDS FC VANGERVEN F ESPINELINGROFF A BARTLETT MS GHANNOUM MA LANCASTER MV PFALLER MA REX JH RINALDI MG WALSH TJ
Citation: Fc. Odds et al., EVALUATION OF POSSIBLE CORRELATIONS BETWEEN ANTIFUNGAL SUSCEPTIBILITIES OF FILAMENTOUS FUNGI IN-VITRO AND ANTIFUNGAL TREATMENT OUTCOMES IN ANIMAL INFECTION MODELS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 282-288

Authors: REX JH NELSON PW PAETZNICK VL LOZANOCHIU M ESPINELINGROFF A ANAISSIE EJ
Citation: Jh. Rex et al., OPTIMIZING THE CORRELATION BETWEEN RESULTS OF TESTING IN-VITRO AND THERAPEUTIC OUTCOME IN-VIVO FOR FLUCONAZOLE BY TESTING CRITICAL ISOLATESIN A MURINE MODEL OF INVASIVE CANDIDIASIS, Antimicrobial agents and chemotherapy, 42(1), 1998, pp. 129-134

Authors: REX JH PFALLER MA GALGIANI JN BARTLETT MS ESPINELINGROFF A GHANNOUM MA LANCASTER M ODDS FC RINALDI MG WALSH TJ BARRY AL
Citation: Jh. Rex et al., DEVELOPMENT OF INTERPRETIVE BREAKPOINTS FOR ANTIFUNGAL SUSCEPTIBILITYTESTING - CONCEPTUAL-FRAMEWORK AND ANALYSIS OF IN-VITRO IN-VIVO CORRELATION DATA FOR FLUCONAZOLE, ITRACONAZOLE, AND CANDIDA INFECTIONS, Clinical infectious diseases, 24(2), 1997, pp. 235-247

Authors: ESPINELINGROFF A
Citation: A. Espinelingroff, CLINICAL RELEVANCE OF ANTIFUNGAL RESISTANCE, Infectious disease clinics of North America, 11(4), 1997, pp. 929

Authors: ESPINELINGROFF A BARTLETT M BOWDEN R CHIN NX COOPER C FOTHERGILL A MCGINNIS MR MENEZES P MESSER SA NELSON PW ODDS FC PASARELL L PETER J PFALLER MA REX JH RINALDI MG SHANKLAND GS WALSH TJ WEITZMAN I
Citation: A. Espinelingroff et al., MULTICENTER EVALUATION OF PROPOSED STANDARDIZED PROCEDURE FOR ANTIFUNGAL SUSCEPTIBILITY TESTING OF FILAMENTOUS FUNGI, Journal of clinical microbiology, 35(1), 1997, pp. 139-143

Authors: ESPINELINGROFF A
Citation: A. Espinelingroff, HISTORY OF MEDICAL MYCOLOGY IN THE UNITED-STATES, Clinical microbiology reviews, 9(2), 1996, pp. 235

Authors: ESPINELINGROFF A QUART A STEELEMOORE L METCHEVA I BUCK GA BRUZZESE VL REICH D
Citation: A. Espinelingroff et al., MOLECULAR KARYOTYPING OF MULTIPLE YEAST SPECIES ISOLATED FROM 9 PATIENTS WITH AIDS DURING PROLONGED FLUCONAZOLE THERAPY, Journal of medical and veterinary mycology, 34(2), 1996, pp. 111-116

Authors: SANATI H MESSER SA PFALLER M WITT M LARSEN R ESPINELINGROFF A GHANNOUM M
Citation: H. Sanati et al., MULTICENTER EVALUATION OF BROTH MICRODILUTION METHOD FOR SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS AGAINST FLUCONAZOLE, Journal of clinical microbiology, 34(5), 1996, pp. 1280-1282

Authors: ESPINELINGROFF A PFALLER M ERWIN ME JONES RN
Citation: A. Espinelingroff et al., INTERLABORATORY EVALUATION OF ETEST METHOD FOR TESTING ANTIFUNGAL SUSCEPTIBILITIES OF PATHOGENIC YEASTS TO 5 ANTIFUNGAL AGENTS BY USING CASITONE AGAR AND SOLIDIFIED RPMI-1640 MEDIUM WITH 2-PERCENT GLUCOSE, Journal of clinical microbiology, 34(4), 1996, pp. 848-852

Authors: ANAISSIE EJ PAETZNICK VL ENSIGN LG ESPINELINGROFF A GALGIANI JN HITCHCOCK CA LAROCCO M PATTERSON T PFALLER MA REX JH RINALDI MG
Citation: Ej. Anaissie et al., MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTING OF CANDIDA-ALBICANS AND CRYPTOCOCCUS-NEOFORMANS WITH AND WITHOUT AGITATION - AN 8-CENTER COLLABORATIVE STUDY, Antimicrobial agents and chemotherapy, 40(10), 1996, pp. 2387-2391

Authors: QUART AM ESPINELINGROFF A REICH D
Citation: Am. Quart et al., FLUCONAZOLE FOR REFRACTORY OROPHARYNGEAL CANDIDIASIS IN AIDS PATIENTS, AIDS patient care, 9(2), 1995, pp. 56-59

Authors: STGERMAIN G DION C ESPINELINGROFF A RATELLE J DEREPENTIGNY L
Citation: G. Stgermain et al., KETOCONAZOLE AND ITRACONAZOLE SUSCEPTIBILITY OF CANDIDA-ALBICANS ISOLATED FROM PATIENTS INFECTED WITH HIV, Journal of antimicrobial chemotherapy, 36(1), 1995, pp. 109-118

Authors: PFALLER MA BALE M BUSCHELMAN B LANCASTER M ESPINELINGROFF A REX JH RINALDI MG COOPER CR MCGINNIS MR
Citation: Ma. Pfaller et al., QUALITY-CONTROL GUIDELINES FOR NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS RECOMMENDED BROTH MACRODILUTION TESTING OF AMPHOTERICIN-B, FLUCONAZOLE, AND FLUCYTOSINE, Journal of clinical microbiology, 33(5), 1995, pp. 1104-1107

Authors: ESPINELINGROFF A RODRIGUEZTUDELA JL MARTINEZSUAREZ JV
Citation: A. Espinelingroff et al., COMPARISON OF 2 ALTERNATIVE MICRODILUTION PROCEDURES WITH THE TIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS REFERENCE MACRODILUTION METHOD M27-P FOR IN-VITRO TESTING OF FLUCONAZOLE-RESISTANT AND FLUCONAZOLE-SUSCEPTIBLE ISOLATES OF CANDIDA-ALBICANS, Journal of clinical microbiology, 33(12), 1995, pp. 3154-3158

Authors: ESPINELINGROFF A DAWSON K PFALLER M ANAISSIE E BRESLIN B DIXON D FOTHERGILL A PAETZNICK V PETER J RINALDI M WALSH T
Citation: A. Espinelingroff et al., COMPARATIVE AND COLLABORATIVE EVALUATION OF STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING FOR FILAMENTOUS FUNGI, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 314-319

Authors: ESPINELINGROFF A STEELEMOORE L GALGIANI JN
Citation: A. Espinelingroff et al., EVALUATION OF 80-PERCENT INHIBITION STANDARDS FOR THE DETERMINATION OF FLUCONAZOLE MINIMUM INHIBITORY CONCENTRATIONS IN 3 LABORATORIES, Diagnostic microbiology and infectious disease, 20(2), 1994, pp. 81-86

Authors: ESPINELINGROFF A STEELEMOORE L
Citation: A. Espinelingroff et L. Steelemoore, COMPARISON OF FLUCONAZOLE MINIMUM INHIBITORY CONCENTRATIONS IN 3 DIFFERENT FORMULATIONS OF RPMI-1640, Diagnostic microbiology and infectious disease, 20(2), 1994, pp. 87-91

Authors: ESPINELINGROFF A
Citation: A. Espinelingroff, ETEST FOR ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS, Diagnostic microbiology and infectious disease, 19(4), 1994, pp. 217-220

Authors: PFALLER MA BUSCHELMAN B BALE MJ LANCASTER M ESPINELINGROFF A REX JH RINALDI MG
Citation: Ma. Pfaller et al., MULTICENTER COMPARISON OF A COLORIMETRIC MICRODILUTION BROTH METHOD WITH THE REFERENCE MACRODILUTION METHOD FOR IN-VITRO SUSCEPTIBILITY TESTING OF YEAST ISOLATES, Diagnostic microbiology and infectious disease, 19(1), 1994, pp. 9-13

Authors: PFALLER MA VU Q LANCASTER M ESPINELINGROFF A FOTHERGILL A GRANT C MCGINNIS MR PASARELL L RINALDI MG STEELEMOORE L
Citation: Ma. Pfaller et al., MULTISITE REPRODUCIBILITY OF COLORIMETRIC BROTH MICRODILUTION METHOD FOR ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEAST ISOLATES, Journal of clinical microbiology, 32(7), 1994, pp. 1625-1628
Risultati: 1-25 | 26-28